{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:12:56Z","timestamp":1778919176844,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR717"],"award-info":[{"award-number":["2017SGR717"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00287"],"award-info":[{"award-number":["PI16\/00287"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","award":["SAF2015-68346-P"],"award-info":[{"award-number":["SAF2015-68346-P"]}],"id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejphar.2023.175802","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T19:14:10Z","timestamp":1686165250000},"page":"175802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D1 and D2 receptors"],"prefix":"10.1016","volume":"953","author":[{"given":"Maurizio S.","family":"Riga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Didriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Celada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175802_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2023.175802_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2023.175802_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyac003","article-title":"The dual 5-HT3 and 5-HT6 receptor antagonist FPPQ normalizes phencyclidine-induced disruption of brain oscillatory activity in rats","author":"Casta\u00f1\u00e9","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2023.175802_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2018.09.015","article-title":"Serotonin2Breceptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons","volume":"311","author":"Cathala","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2023.175802_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.conb.2014.09.001","article-title":"The thalamocortical network as a single slow wave-generating unit","volume":"31","author":"Crunelli","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175802_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02246069","article-title":"Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia","volume":"121","author":"Den Boer","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2023.175802_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","article-title":"The use of c-fos as a metabolic marker in neuronal pathway tracing","volume":"29","author":"Dragunow","year":"1989","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2023.175802_bib8","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1007\/BF00442555","article-title":"D-1 and D-2 dopamine receptor occupancy during treatment with conventional and atypical neuroleptics","volume":"99","author":"Farde","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2023.175802_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2021.03.035","article-title":"D2 receptors in the periaqueductal gray\/dorsal raphe modulate peripheral inflammatory hyperalgesia via the rostral ventral medulla","volume":"463","author":"Ferrari","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2023.175802_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(76)90284-5","article-title":"Determination of antidromic excitation by the collision test: problems of interpretation","volume":"112","author":"Fuller","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2023.175802_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejphar.2023.175802_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"10 Suppl. l","key":"10.1016\/j.ejphar.2023.175802_bib13","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","volume":"23","author":"Gerfen","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2023.175802_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175802_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/026988119701100202","article-title":"The anatomical relationships of the prefrontal cortex with limbic structures and the basal ganglia","volume":"11","author":"Groenewegen","year":"1997","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2023.175802_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(00)26003-2","article-title":"The prefrontal cortex and the integration of sensory, limbic and autonomic information","volume":"126","author":"Groenewegen","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejphar.2023.175802_bib17","article-title":"Distal kinetic deuterium isotope effect: phenyl ring deuteration attenuates N-demethylation of Lu AF35700","author":"Jensen","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2023.175802_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.schres.2022.09.012","article-title":"DayBreak and Debut study investigators. Efficacy and safety of Lu AF35700 in treatment-resistant schizophrenia: a randomized, active-controlled trial with open-label extension","volume":"248","author":"Kane","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2023.175802_bib19","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc Natl AcadSci U S A"},{"key":"10.1016\/j.ejphar.2023.175802_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/npp.2011.249","article-title":"Clozapine reverses phencyclidine-induced desynchronization of prefrontal cortex through a 5-HT(1A) receptor-dependent mechanism","volume":"37","author":"Kargieman","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2023.175802_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175802_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/REVNEURO.2004.15.6.383","article-title":"Tracing the neuroanatomical profiles of reward pathways with markers of neuronal activation","volume":"15","author":"Konkle","year":"2004","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175802_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2023.175802_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.euroneuro.2015.11.015","article-title":"Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: effects of antipsychotic drugs and receptor ligands","volume":"26","author":"Llad\u00f3-Pelfort","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2023.175802_bib25","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/0197-0186(92)90208-9","article-title":"Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain","author":"Mengod","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2023.175802_bib27","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.ejphar.2023.175802_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhh104","article-title":"Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA","volume":"15","author":"Puig","year":"2005","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.ejphar.2023.175802_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2016.04.023","article-title":"Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission","volume":"108","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.175802_bib30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/cercor\/bhn134","article-title":"Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"19","author":"Santana","year":"2009","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.ejphar.2023.175802_bib31","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","article-title":"Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine","volume":"69","author":"Santana","year":"2011","journal-title":"Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.ejphar.2023.175802_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnana.2017.00087","article-title":"Laminar and cellular distribution of monoamine receptors in rat medial prefrontal cortex","volume":"28","author":"Santana","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ejphar.2023.175802_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3371\/CSRP.4.1.5","article-title":"Dopamine D2 receptors as treatment targets in schizophrenia","volume":"4","author":"Seeman","year":"2010","journal-title":"Clin. Schizophrenia Relat. Psychoses"},{"key":"10.1016\/j.ejphar.2023.175802_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-4328(01)00223-6","article-title":"Histamine reduces firing and bursting of anterior and intralaminar thalamic neurons and activates striatal cells in anesthetized rats","volume":"124","author":"Sittig","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2023.175802_bib35","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1176\/appi.ajp.161.9.1620","article-title":"Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics","volume":"161","author":"Tauscher","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2023.175802_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biopsych.2014.05.019","article-title":"Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain","volume":"76","author":"Troyano-Rodriguez","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2023.175802_bib37","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.euroneuro.2017.10.034","article-title":"The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks","volume":"27","author":"van den Munkhof","year":"2017","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2023.175802_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrn2733","article-title":"What does the retrosplenial cortex do?","volume":"10","author":"Vann","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2023.175802_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1461145710000349","article-title":"Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei","volume":"14","author":"V\u00e1zquez-Borsetti","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2023.175802_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0014-2999(90)91368-L","article-title":"Neuroleptic\/dopamine receptors","volume":"183","author":"Waddington","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175802_bib42","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0278-5846(90)90046-J","article-title":"Central D1- and D2-receptor occupancy during antipsychotic drug treatment","volume":"14","author":"Wiesel","year":"1990","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2023.175802_bib43","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1021\/acs.jmedchem.1c00224","article-title":"Structure-based design and optimization of FPPQ, a dual-acting 5-HT3 and 5-HT6 receptor antagonist with antipsychotic and procognitive properties","volume":"64","author":"Zajdel","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923003138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:23:37Z","timestamp":1762143817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923003138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":41,"alternative-id":["S0014299923003138"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175802","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D1 and D2 receptors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175802"}}